BioPharma DiveOriginal article
Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds
Positive
AI Analysis
Summary
Forbion raised $2.6B for a pair of venture funds, marking its largest fundraise to date. The funding aims to support European biotech development as the region seeks to close the gap with U.S. and Chinese counterparts.
Importance:5/10
Sentiment:
0.60
venture fundingbiotech investmentEuropean biotechfund raising
Related Companies
Read the original article
Published by BioPharma Dive on October 6, 2026 6:04 PM
